PMID- 19825843 OWN - NLM STAT- MEDLINE DCOM- 20100309 LR - 20211020 IS - 1460-2083 (Electronic) IS - 0964-6906 (Print) IS - 0964-6906 (Linking) VI - 19 IP - 1 DP - 2010 Jan 1 TI - MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double-stranded RNA. PG - 135-46 LID - 10.1093/hmg/ddp474 [doi] AB - beta-Cell destruction in type 1 diabetes (T1D) is at least in part consequence of a 'dialog' between beta-cells and immune system. This dialog may be affected by the individual's genetic background. We presently evaluated whether modulation of MDA5 and PTPN2, two candidate genes for T1D, affects beta-cell responses to double-stranded RNA (dsRNA), a by-product of viral replication. These genes were selected following comparison between known candidate genes for T1D and genes expressed in pancreatic beta-cells, as identified in previous array analysis. INS-1E cells and primary fluorescence-activated cell sorting-purified rat beta-cells were transfected with small interference RNAs (siRNAs) targeting MDA5 or PTPN2 and subsequently exposed to intracellular synthetic dsRNA (polyinosinic-polycitidilic acid-PIC). Real-time RT-PCR, western blot and viability assays were performed to characterize gene/protein expression and viability. PIC increased MDA5 and PTPN2 mRNA expression, which was inhibited by the specific siRNAs. PIC triggered apoptosis in INS-1E and primary beta-cells and this was augmented by PTPN2 knockdown (KD), although inhibition of MDA5 did not modify PIC-induced apoptosis. In contrast, MDA5 silencing decreased PIC-induced cytokine and chemokine expression, although inhibition of PTPN2 induced minor or no changes in these inflammatory mediators. These findings indicate that changes in MDA5 and PTPN2 expression modify beta-cell responses to dsRNA. MDA5 regulates inflammatory signals, whereas PTPN2 may function as a defence mechanism against pro-apoptotic signals generated by dsRNA. These two candidate genes for T1D may thus modulate beta-cell apoptosis and/or local release of inflammatory mediators in the course of a viral infection by acting, at least in part, at the pancreatic beta-cell level. FAU - Colli, Maikel L AU - Colli ML AD - Laboratory of Experimental Medicine, Universite Libre de Bruxelles, Brussels, Belgium. FAU - Moore, Fabrice AU - Moore F FAU - Gurzov, Esteban N AU - Gurzov EN FAU - Ortis, Fernanda AU - Ortis F FAU - Eizirik, Decio L AU - Eizirik DL LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Hum Mol Genet JT - Human molecular genetics JID - 9208958 RN - 0 (Chemokines) RN - 0 (NF-kappa B) RN - 0 (RNA, Double-Stranded) RN - 0 (RNA, Small Interfering) RN - 77238-31-4 (Interferon-beta) RN - EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases) RN - EC 3.1.3.48 (Protein Tyrosine Phosphatase, Non-Receptor Type 2) RN - EC 3.1.3.48 (Ptpn2 protein, rat) RN - EC 3.6.4.13 (DEAD-box RNA Helicases) RN - O84C90HH2L (Poly I-C) SB - IM MH - Animals MH - Apoptosis/drug effects MH - Chemokines/metabolism MH - DEAD-box RNA Helicases/*metabolism MH - Diabetes Mellitus, Type 1/*enzymology/*genetics MH - Enzyme Activation/drug effects MH - Insulin-Secreting Cells/enzymology/*pathology MH - Interferon-beta/genetics MH - JNK Mitogen-Activated Protein Kinases/metabolism MH - Male MH - NF-kappa B/metabolism MH - Poly I-C/pharmacology MH - Promoter Regions, Genetic/genetics MH - Protein Tyrosine Phosphatase, Non-Receptor Type 2/*metabolism MH - RNA, Double-Stranded/*pharmacology MH - RNA, Small Interfering/metabolism MH - Rats MH - Rats, Wistar MH - Viruses/*metabolism PMC - PMC2792153 EDAT- 2009/10/15 06:00 MHDA- 2010/03/10 06:00 PMCR- 2009/10/13 CRDT- 2009/10/15 06:00 PHST- 2009/10/15 06:00 [entrez] PHST- 2009/10/15 06:00 [pubmed] PHST- 2010/03/10 06:00 [medline] PHST- 2009/10/13 00:00 [pmc-release] AID - ddp474 [pii] AID - 10.1093/hmg/ddp474 [doi] PST - ppublish SO - Hum Mol Genet. 2010 Jan 1;19(1):135-46. doi: 10.1093/hmg/ddp474.